Glaukos Corporation(6GJ)

Description: Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

---

Keywords: Ophthalmology Glaucoma Cataracts Blindness Eye Surgery Bypass Ocular Hypertension Retinal Diseases Treatment Of Glaucoma Cataract Surgery Open Angle Glaucoma Intraocular Pressure Minimally Invasive Glaucoma Surgery

---

Home Page: www.glaukos.com

One Glaukos Way
Aliso Viejo, CA 92656
United States
Phone: 949 367 9600

---

Officers

Exchange: F

Country: DE : Germany

Currency: Euro (€)